In a legal development on Tuesday, OpenAI and Microsoft found themselves at the center of a lawsuit, accused of improperly utilizing the works of nonfiction authors to train artificial intelligence (AI) models, including OpenAI’s widely-used chatbot, ChatGPT.
The proposed class action, filed in Manhattan federal court, is spearheaded by Julian Sancton, an author and editor at the Hollywood Reporter. Sancton alleges that OpenAI copied tens of thousands of nonfiction books without proper authorization to educate its large language models, enabling them to generate responses to human text prompts.
This lawsuit is part of a broader trend, with several groups of copyright owners, including acclaimed authors such as John Grisham, George R.R. Martin, and Jonathan Franzen, initiating legal action against OpenAI and other tech companies. The authors claim that their literary works were utilized without consent in training AI systems, leading to concerns about intellectual property rights.
Read more: Microsoft To Invest More In OpenAI, As It Looks To Compete With Google In AI
Notably, Julian Sancton’s complaint stands out as the first author-initiated lawsuit against OpenAI that also implicates Microsoft as a defendant. Microsoft, a major player in the tech industry, has invested substantial funds in OpenAI and seamlessly integrated the startup’s AI systems into its own products.
Both OpenAI and Microsoft have firmly denied the allegations brought forth in the lawsuit. The legal battle adds another layer of complexity to the ongoing discourse surrounding the ethical use of copyrighted material in the development of AI technologies. As the case unfolds, it will likely shed light on the evolving landscape of intellectual property rights in the age of artificial intelligence.
Source: Reuters
Featured News
Subscribers Defend $4.7 Billion Antitrust Verdict Against NFL in Court Filings
Jul 19, 2024 by
CPI
Von der Leyen Calls for Competition Policy to Boost EU Companies’ Growth
Jul 19, 2024 by
CPI
Vermont AG Sues Pharmacy Benefit Managers Over Drug Prices
Jul 18, 2024 by
CPI
Australians Face Increased Stamp Prices Following ACCC Approval
Jul 18, 2024 by
CPI
Live Nation Seeks Dismissal of DOJ Antitrust Allegations
Jul 18, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Private Equity Roll-Up Schemes
Jun 28, 2024 by
CPI
The FTC’s Focus on Private Equity is Warranted
Jun 28, 2024 by
CPI
Unraveling the Roll-Up: Private Equity’s Misunderstood Investment Strategy
Jun 28, 2024 by
CPI
Antitrust Focus on Private Equity Funds and Serial Acquisitions
Jun 28, 2024 by
CPI
Private Equity Roll-Ups Amidst Heightened Antitrust Enforcement
Jun 28, 2024 by
CPI